Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program
By: Colorado BioScience Association Date: 12/09/2020
Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing orally bioavailable, small molecule therapies for musculoskeletal diseases, today announced the closing of a $95 million Se...
Learn MoreSomaLogic Closes $121M Series A Financing Led by Casdin Capital
By: Colorado BioScience Association Date: 11/25/2020
SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that the Company has successfully closed an Initial S...
Learn More$7.7 Million Advanced Industries Awards Fuel 37 Colorado Start-ups
By: Colorado BioScience Association Date: 11/19/2020
Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program realeased a list of 37 Colorado start-ups approved for funding. A total of...
Learn MorePrima-Temp Awarded Groundbreaking Patent Using Artificial Intelligence For Ovulation Prediction
By: Colorado BioScience Association Date: 11/19/2020
Prima-Temp, Inc., a leader in developing digital health solutions through chronobiology, has been awarded a patent recognizing its innovative approach to applying artificial intelligence (AI) to women...
Learn MoreBoulder-based biotech SomaLogic has entered a five-year partnership with the Food & Drug Administration
By: Colorado BioScience Association Date: 11/11/2020
It can be very difficult to manufacture generic versions of biologic drugs. But SomaLogic has a test that can help determine whether a new drug candidate is similar enough to the original drug to be c...
Learn MoreL7 Informatics Automates Lab Operations and Supports Washington University School of Medicine with Workflow for Its Saliva-based COVID-19 Test
By: Colorado BioScience Association Date: 11/10/2020
L7 Informatics announced that it has deployed L7 | ESP to automate all lab operations starting with COVID-related workflow at the Genome Technology Access Center (GTAC@MGI) in the McDonnell Genome Ins...
Learn MoreTo Support Go/No-Go Decisions in Early Drug Development, Inotiv Got It Together — Fast
By: Colorado BioScience Association Date: 11/02/2020
Pharmaceutical and medical device companies are always under pressure to improve research productivity. Increasingly, they rely on contract research organizations (CROs) for access to specific experti...
Learn MoreLightDeck Diagnostics Raises $11 Million Series B to Offer Five-Minute Affordable COVID-19 Tests, Taking the ‘Point-of-Care’ Anywhere
By: Colorado BioScience Association Date: 10/29/2020
LightDeck Diagnostics today announced $11 million in Series B financing from Incubic, Entrada and Boulder Ventures. The funds will support the development and commercialization of in vitro multiplex t...
Learn MoreBoulder biotech Biodesix CEO: Why timing was right for IPO
By: Colorado BioScience Association Date: 10/28/2020
In an exclusive interview, CEO Scott Hutton talks about the next steps for the company, which specializes in blood-based diagnostic tests for lung diseases. Find out more in the Denver Business Journa...
Learn MoreBoulder biotech company Inscripta names new CEO
By: Colorado BioScience Association Date: 10/27/2020
The company has been growing over the past several years, and recently went to market with its genomic engineering platform. Learn more in the Denver Business Journal article.
Learn More